These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Molecular and genetic features of gastrointestinal stromal tumors (GIST)]. Buleje S J, Yábar B A, Guevara-Fujita M, Fujita R. Rev Gastroenterol Peru; 2012; 32(4):394-9. PubMed ID: 23307090 [Abstract] [Full Text] [Related]
4. [Gastrointestinal stromal tumor molecular diagnostics in relation to the prediction of a therapeutic response to targeted biological therapy]. Augustináková A, Kodet R. Cesk Patol; 2011 Oct; 47(4):148-52. PubMed ID: 22145212 [Abstract] [Full Text] [Related]
5. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Lasota J, Miettinen M. Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355 [Abstract] [Full Text] [Related]
6. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors. Daum O, Grossmann P, Vanecek T, Sima R, Mukensnabl P, Michal M. Ann Diagn Pathol; 2007 Feb; 11(1):27-33. PubMed ID: 17240304 [Abstract] [Full Text] [Related]
15. [Gastrointestinal stromal tumors: a rare nosological entity and a model example for the use of personalized therapy with a molecular basis]. Bettegazzi C, Erra S. Recenti Prog Med; 2015 Jan; 106(1):52-7. PubMed ID: 25621782 [Abstract] [Full Text] [Related]
17. Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients. Valadão M, Braggio D, Santos AF, Pimenta-Inada HK, Linhares E, Gonçalves R, Romano S, Vilhena B, Small I, Cubero D, Cruz F, Oliveira AT, Martinho O, Reis RM, Guimarães DP, Ferreira CG. J Surg Res; 2012 Nov; 178(1):288-93. PubMed ID: 22516345 [Abstract] [Full Text] [Related]